Spearhead Capital Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-7,715
| Closed | -$317K | – | 181 |
|
|
2021
Q3 | $317K | Sell |
7,715
-334
| -4% | -$13.7K | 0.04% | 147 |
|
|
2021
Q2 | $456K | Sell |
8,049
-377
| -4% | -$21.4K | 0.06% | 121 |
|
|
2021
Q1 | $354K | Buy |
8,426
+399
| +5% | +$16.8K | 0.05% | 119 |
|
|
2020
Q4 | $563K | Sell |
8,027
-928
| -10% | -$65.1K | 0.09% | 90 |
|
|
2020
Q3 | $251K | Hold |
8,955
| – | – | 0.05% | 155 |
|
|
2020
Q2 | $265K | Buy |
+8,955
| New | +$265K | 0.06% | 121 |
|
|
2020
Q1 | – | Sell |
-9,985
| Closed | -$296K | – | 117 |
|
|
2019
Q4 | $296K | Buy |
+9,985
| New | +$296K | 0.07% | 78 |
|